Suzanne S. Gisbertz
Amsterdam University Medical Centers, Amsterdam UMC Location University of Amsterdam
Papers
10
Total Citations
305
H-Index
6
About
Suzanne S. Gisbertz is a leading figure in esophageal cancer surgery, with her research centered on advancing minimally invasive and robot-assisted techniques for esophagectomy. Her major contributions include pioneering the ROBOT-2 trial, a landmark randomized controlled trial comparing robot-assisted minimally invasive esophagectomy (RAMIE) to conventional minimally invasive esophagectomy (MIE) for resectable esophageal adenocarcinoma, which has garnered over 100 citations. She has also led international efforts through the Upper GI International Robotic Association (UGIRA), creating the first worldwide registry to standardize and evaluate RAMIE outcomes, with studies cited over 70 times. Her work has been instrumental in demonstrating the feasibility and safety of robotic approaches, including novel single-port techniques and the use of the hinotori™ system. With a cumulative citation count exceeding 300, Gisbertz has shaped the evolution of surgical approaches for esophageal cancer, from open to minimally invasive to robotic methods. Her notable achievements include defining optimal anastomotic techniques to reduce leakage and tracking the nationwide adoption of robot-assisted surgery in the Netherlands, solidifying her role as a key innovator in upper gastrointestinal oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3The evolution of surgical approach for esophageal cancer54 citations · 2018
- 4
- 5
- 6Laparoscopic surgery for gastro-esophageal acid reflux disease19 citations · 2013
- 7Hinotori™ robotic esophagectomy: a feasibility cadaver study5 citations · 2024
- 8
- 9
- 10The Rise of Robot-Assisted Surgery in the Netherlands1 citations · 2025